乳腺癌患者乳房切除术后放疗——作者回复 - Suppr

Suppr

超能文献

Postmastectomy radiotherapy in patients with breast cancer - Authors' reply.

机构信息

Early Breast Cancer Trialists' Collaborative Group Secretariat, Clinical Trial Service Unit, Oxford OX3 7LF, UK.

出版信息

Lancet. 2014 Nov 22;384(9957):1846-1847. doi: 10.1016/S0140-6736(14)62240-6. Epub 2014 Nov 21.

DOI:10.1016/S0140-6736(14)62240-6

PMID:25457913

Abstract

摘要

相似文献

Postmastectomy radiotherapy in patients with breast cancer - Authors' reply.

Lancet. 2014 Nov 22;384(9957):1846-1847. doi: 10.1016/S0140-6736(14)62240-6. Epub 2014 Nov 21.

Postmastectomy radiotherapy in patients with breast cancer.

Lancet. 2014 Nov 22;384(9957):1844-1845. doi: 10.1016/S0140-6736(14)62237-6. Epub 2014 Nov 21.

Postmastectomy radiotherapy in patients with breast cancer.

Lancet. 2014 Nov 22;384(9957):1845. doi: 10.1016/S0140-6736(14)62238-8. Epub 2014 Nov 21.

Postmastectomy radiotherapy in patients with breast cancer.

Lancet. 2014 Nov 22;384(9957):1846. doi: 10.1016/S0140-6736(14)62239-X. Epub 2014 Nov 21.

Radiotherapy or surgery for the axilla in node-positive breast cancer?--authors' reply.

Lancet Oncol. 2015 Feb;16(2):e54. doi: 10.1016/S1470-2045(15)70008-2.

Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate.

Lancet. 2014 Jun 21;383(9935):2104-6. doi: 10.1016/S0140-6736(14)60192-6. Epub 2014 Mar 19.

Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapy.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):758-64. doi: 10.1016/j.ijrobp.2010.02.014. Epub 2010 Jun 18.

Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.

Jpn J Clin Oncol. 2012 Aug;42(8):711-20. doi: 10.1093/jjco/hys080. Epub 2012 May 29.

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

Radiother Oncol. 2009 Jan;90(1):74-9. doi: 10.1016/j.radonc.2008.04.014. Epub 2008 May 28.

Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

J Natl Cancer Inst. 2006 Jul 19;98(14):1020-1; author reply 1021-2. doi: 10.1093/jnci/djj279.

引用本文的文献

Hijacking homeostasis: the brain-body neural circuitry in tumor pathogenesis and emerging therapeutic frontiers.

Mol Cancer. 2025 Jul 25;24(1):206. doi: 10.1186/s12943-025-02396-6.

Engineering Folic Acid-Modified Nanoparticles to Enhance Letrozole's Anticancer Action.

Macromol Biosci. 2025 Jul;25(7):e2400558. doi: 10.1002/mabi.202400558. Epub 2025 Apr 18.

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.

Clin Transl Radiat Oncol. 2022 Aug 28;37:71-77. doi: 10.1016/j.ctro.2022.08.013. eCollection 2022 Nov.

Engineering Alendronate-Composed Iron Nanochelator for Efficient Peritoneal Carcinomatosis Treatment.

Adv Sci (Weinh). 2022 Oct;9(30):e2203031. doi: 10.1002/advs.202203031. Epub 2022 Sep 4.

Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.

Cardiooncology. 2022 Jul 19;8(1):13. doi: 10.1186/s40959-022-00139-w.

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Lancet Oncol. 2022 Mar;23(3):382-392. doi: 10.1016/S1470-2045(21)00758-0. Epub 2022 Feb 3.

Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.

J Natl Cancer Inst. 2022 Jun 13;114(6):819-828. doi: 10.1093/jnci/djab218.

Proton Therapy for Partial Breast Irradiation: Rationale and Considerations.

J Pers Med. 2021 Apr 9;11(4):289. doi: 10.3390/jpm11040289.

Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer.

Eur J Surg Oncol. 2021 Feb;47(2):261-268. doi: 10.1016/j.ejso.2020.09.029. Epub 2020 Sep 30.

CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells.

J Nat Prod. 2020 Oct 23;83(10):3080-3092. doi: 10.1021/acs.jnatprod.0c00642. Epub 2020 Oct 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验